NFKB1 and colonic neoplasm: Numerous molecular targets of CUR have already been detected in colon cancer cell lines, along with its well-defined activity in inhibiting the COX-2 and NF-κB signaling pathway as well as other recognized processes of stimulating apoptosis (Figure 3) [251,252,253,254,255].